← Leaderboards
Robert D Sanders
Vanderbilt University Medical Center
$3,433,566
Attributed
$5,710,065
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,710,065 · 4
By mechanism
R01$4,406,063 · 1
R21$820,906 · 2
K23$483,096 · 1
Top collaborators
- Robert A Pearce4 shared
- Ben Julian Palanca3 shared
- Christopher Hughes2 shared
- Richard C Lennertz1 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- E Wesley Ely$22,934,169
- Mayur B Patel$10,041,667
- Lorraine B Ware$25,185,641
- Angela L. Jefferson$48,680,773
- Heidi A B Smith$2,104,103
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposPostoperative DeliriumPathogenesisDeliriumImpaired CognitionInsightPublic HealthLightOperative Surgical ProceduresBiological MarkersCostNeurofilamentPreventPlasmaPerioperativeSeveritiesInflammationDementiaDensityCytokineMortalityMorbidity - Disease RateCognitiveAcute
Grant awards (14)
Clarifying the overlapping pathology of delirium and dementia$711,643
R01 · FY2025 · AG
Mitigating Delirium with Fluvoxamine Treatment for Non-Cardiac Surgery (MD FluNCS): Feasibility Trials & Mechanistic Insights$107,129
R21 · FY2025 · AG
Mitigating Delirium with Fluvoxamine Treatment for Non-Cardiac Surgery (MD FluNCS): Feasibility Trials & Mechanistic Insights$60,596
R21 · FY2025 · AG
Mitigating Delirium with Fluvoxamine Treatment for Non-Cardiac Surgery (MD FluNCS): Feasibility Trials & Mechanistic Insights$215,425
R21 · FY2024 · AG
Delirium, Long-Term Cognition and the Dementia Pathological Trajectory$87,145
R21 · FY2024 · AG
Clarifying the overlapping pathology of delirium and dementia$770,447
R01 · FY2023 · AG
Delirium, Long-Term Cognition and the Dementia Pathological Trajectory$350,611
R21 · FY2023 · AG
Clarifying the overlapping pathology of delirium and dementia$769,730
R01 · FY2022 · AG
Clarifying the overlapping pathology of delirium and dementia$747,032
R01 · FY2021 · AG
Clarifying the overlapping pathology of delirium and dementia$733,240
R01 · FY2020 · AG
The Cognitive Disintegration Model of Delirium: A Clinical Cohort Study Investigating Neural Network Connectivity and Local Slow Wave Activity$74,098
K23 · FY2020 · AG · contact PI
Clarifying the overlapping pathology of delirium and dementia$673,971
R01 · FY2019 · AG · contact PI
The Cognitive Disintegration Model of Delirium: A Clinical Cohort Study Investigating Neural Network Connectivity and Local Slow Wave Activity$204,499
K23 · FY2019 · AG · contact PI
The Cognitive Disintegration Model of Delirium: A Clinical Cohort Study Investigating Neural Network Connectivity and Local Slow Wave Activity$204,499
K23 · FY2018 · AG · contact PI